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Neomycin was used to assess the involvement of Ins (1,4,5)P, in the CaZ+ release from the endoplasmic reticulum induced 
by the bile acid taurolithocholate. In saponin-penneabilized rat hepatocytes, neomycin via its ability to bind Ins (1,4,5)P, 
abolished the release of Ca*+ Induced by added Ins (1,4,5)P,. In contrast, it did not alter the Ca*+ release initiated by 
the bile acid. In intact cells, neomycin had no effect on the [Ca2+], rises promoted by taurolithocholate and vasopressin. 
It is suggested that the effect of taurolithocholate in liver is not mediated by Ins (1,4,5)P, but results from a primary 
action on endoplasmic reticulum. 
CaZ+; Bile acid; Endoplasmic reticulum; Neomycin; (Rat liver) 
1. INTRODUCTION 
It has been recently found that two natural bile 
acids, lithocholate (LC) and taurolithocholate 
(TLC), mobilize Ca*+ in rat liver [1,2]. In intact 
hepatocytes, these agents promote a fast and tran- 
sient increase of the concentration of the cytosolic 
Ca*+, [Ca*+]i, by mobilizing Ca*+ from the same 
pool as vasopressin [2]. The first action of this hor- 
mone in liver is to cause a rapid breakdown of 
phosphatidylinositol 4,5bisphosphate (PIP*) and 
synthesis of inositol 1,4,5trisphosphate [Ins 
(1,4,5)P3] [3-71 that permeabilizes the en- 
doplasmic reticulum (ER) to Ca*+ [8,9]. When ap- 
plied to saponin-permeabilized hepatocytes, TLC 
and LC induce the release of Ca*+ from a non- 
mitochondrial, ATP-dependent pool that is sen- 
sitive to Ins (1,4,5)P3 [2]. 
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Although TLC and LC mimick the action of 
vasopressin in intact cells and that of Ins (1,4,5)P3 
in saponin-treated cells, it does not alter the basal 
Ins (1,4,5)P3 content of cells [2]. Because of this 
latter observation, we proposed that the bile acid- 
induced Ca*+ release was not mediated by PIP2 
breakdown [2]. However, we could not rule out the 
possibility that a small PIP2 pool was being broken 
down by direct stimulation of phospholipase C by 
TLC and LC. This possibility is reinforced by the 
fact that in liver cells, Ins (1,4,5)P3 is so rapidly 
metabolized and recycled to form PIP2 (within a 
few tens of seconds, see [lo-131) that 
measurements of the level of the inositol 
phosphate may substantially underestimate the ex- 
tent of its formation. 
Here we have used the cationic aminoglycoside 
antibiotic neomycin as a probe to assess the in- 
volvement of Ins (1,4,5)P3 in the TLC-mediated 
Ca*+ release in permeabilized hepatocytes. 
Neomycin, in addition to its ability to bind to 
polyphosphoinositides [14-191 has been shown to 
bind to molecules bearing polyphosphate groups, 
including Ins (1,4,5)P3, thus inhibiting Ca*+ 
mobilization in permeabilized cells [20]. We show 
that neomycin abolishes the Ins (1,4,5)P3_mediated 
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Ca2+ release and has no effect on that promoted by 
TLC, demonstrating that the effect of the bile acid 
is not mediated by Ins (1,4,5)P3, but results from 
a direct action on ER. 
2. MATERIALS AND METHODS 
2.1. Materials 
Materials used for these studies were obtained from the 
following sources: neomycin sulfate from Sigma, quin2 and 
quin2/AM from Lancaster Synthesis, ionomycin from 
Calbiochem and Ins (1,4,5)Ps from Amersham. All other 
chemicals were purchased from Sigma and were of the highest 
purity commercially available. 
2.2. Methods 
Rat hepatocytes were isolated and maintained (2 x lo6 cells 
per ml) in an Eagle’s medium containing 116 mM NaCl, 
5.4 mM KCl, 1.2 mM CaCl2, 0.92 mM NaHzP04, 25 mM 
NaHCOs and 5.6 mM glucose as indicated [21]. The medium 
also contained 15 mg per ml gelatin and vitamins and amino 
acids. It was gassed with 95% 02/5% CO2 (pH 7.4) at 37°C. 
The [Ca’+]i in intact hepatocytes was measured by loading 
cells (2 x lo6 cells per ml) with 50pM quinZ/AM for 150 s. 
Cells were washed and transferred into the cuvette of the spec- 
trofluorimeter (0.4 x lo6 cells per ml) at 37”C, under con- 
tinuous magnetic agitation and gassing with 95% G2/5% Co2 
and [Ca2+]i was calibrated and corrected for autofluorescence 
as in [21]. 
Rat hepatocytes (3 x lo6 cells per ml) were permeabilized as 
reported by Burgess et al. [22]. The cells were incubated in an 
‘internal medium’ containing 20 mM NaCI, 100 mM KCl, 
5 mM MgC12, 0.96 mM NaHzPOd, 25 mM Hepes (pH 7.15 
with KOH) at 37°C. The medium also contained 5 yM of the 
mitochondrial uncoupler CCCP, 1.5 mM ATP, 5 mM creatine 
phosphate and 5 U creatine phosphokinase per ml and 10 FM 
quin2. The concentration of contaminant Ca2’ in this control 
medium as measured by atomic absorption spectroscopy was 
3.26 f 0.25 ,uM (n = 7). In the presence of 1 mM neomycin, the 
contaminant Ca2+ was increased to 7.48 * 0.39 PM (n = 5) in- 
dicating that the antibiotic contains traces of Ca2+. So, the con- 
centration of quin2 was increased to 20 pM in this medium. The 
concentration of free Ca2+ and the amount of Ca2+ released by 
the cells were calculated as in [21]. Determination of protein 
content was carried out by the Lowry method using serum 
albumin as standard protein. 
3. RESULTS 
3.1. Effect of neomycin on intact cells 
The effects of TLC and vasopressin on [Ca’+]i, 
at concentrations of 100 PM and 10 nM, respec- 
tively, which promote maximal Ca2+ movements in 
liver [2-81, are shown in fig.1. In the presence of 
EGTA (1.24 mM) which abolishes Ca2+ influx 
[21,23], the bile acid and the hormone initiated 
transient rises of [Ca’+]i. Examination of the 
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Fig. 1. Lack of effect of neomycin on vasopressin- and TLC- 
mediated [Ca2+]i rises in intact cells loaded with quin2. 
Hepatocytes were incubated in an Eagle’s medium containing 
1.2 mM Ca*‘, then EGTA (E, 1.24 mM) which reduced the 
concentration of external Ca2+ to less than 6 PM [21]. Maximal 
concentrations of TLC (TLC, 1OOrM) and vasopressin (VP, 
10 nM) were added 15 s after EGTA. Addition of the same 
volumes of the respective solvents (4~1 DMSO for TLC and 
deionized water for vasopressin and neomycin) had no effect on 
the [Ca’+]i. Neomycin (1 mM) was added 2 min before EGTA. 
kinetics of the Ca2+ response indicated that the 
peak was maximal at 20 s with TLC and less than 
6 s with vasopressin. The amplitudes of the [Ca2+]i 
rises were not different: TLC increased [Ca2+]i 
from 170 f 9 to 609 f. 44 nM and vasopressin to 
560 + 63 nM (n = 12). The [Ca’+]i then slowly 
returned to basal level within 2-3 min. We have 
shown that these [Ca2+]i rises result from the 
permeabilization of the same internal pool, ER [2]. 
The decreasing phase represents the net extrusion 
of Ca2+ from the cells [2]. The action of TLC was 
dose-dependent with a half-maximal effect ob- 
served at 20 PM. The possibility of artifactual 
Ca2+ contamination by TLC was assessed by 
atomic absorption spectroscopy. No contamina- 
tion was detected by this procedure: the Ca2+ con- 
centration of Eagle’s medium was not affected by 
TLC (100 /IM) and no Ca2+ was detected when the 
agent was added to deionized water. 
Fig. 1 shows the effect of neomycin (1 mM) add- 
ed 2 min before the agents on [Ca2+]i of 
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Fig.2. Neomycin reduces Ins (1,4,5)Ps-mediated Ca’+ release and has no effect on that initiated by TLC in saponin-treated hepatocytes. 
The cells were incubated in the internal medium containing ATP (1.5 mM) and regenerating system, CCCP (5 PM) and quin2. On 
saponin addition, the cells accumulated the contaminant Ca’+ and Ins (1,4,5)P3 (IP3, 1 @M), TLC (1OOpM) then ionomycin (ION, 
5 ,DM) were added when ER had lowered the medium free [Ca”] to about 100 nM. Quin2 fluorescence was calibrated by successive 
additions of EGTA (300,uM) then CaZC (2.5 mM). Neomycin (1 mM) was added 2 min before Ins (1,4,5)P3 and TLC. 
hepatocytes. As expected from a large non- 
permeant molecule, neomycin had no effect on 
basal [Ca’+]i and on the response induced by TLC 
or vasopressin. This is in agreement with other 
studies showing that the cell membrane has to be 
permeabilized to allow neomycin access to the in- 
ner leaflet of the plasma membrane where 
polyphosphoinositides are located [15-l 7,20, 
24-261. 
3.2. Effect of neomycin in saponin-treated cells 
To test whether the effects of TLC were indirect- 
ly mediated by Ins (1,4,5)P3, neomycin was used in 
hepatocytes permeabilized by saponin [22]. Intact 
cells were incubated in the internal medium with 
high [K+], low [Na+], ATP and regenerating 
system, the mitochondrial uncoupler CCCP and 
no added Ca’+. Under these conditions, the 
predominant compartment concentrating Ca2+ is 
ER [8,9,22]. On saponin addition (50 ,ug/ml), cells 
accumulated Ca2+ rapidly and decreased the con- 
taminant Ca2+ from 3 PM (see section 2) to about 
100 nM (fig.2). The addition of Ins (1,4,5)P3 
(1 PM) and TLC (100 FM) caused a rapid release 
of Ca2+ whereas no increase in the fluorescence 
emission was detected when both agents were add- 
ed to a cell-free internal medium. In contrast to 
TLC, the messenger-mediated Ca2+ release (fig.2) 
was transient presumably because of rapid 
degradation of Ins (1,4,5)P3 by cell phosphatases 
[ 10-131. The dose-response curves for the action 
of TLC and Ins (1,4,5)P3 are shown in fig.3A,B. 
The half-maximal effects were observed with 
300 nM Ins (1,4,5)P3 and 20 FM TLC. Maximal 
concentrations of TLC and Ins (1,4,5)Ps released 
90% of the Ca2+ mobilized by the Ca2+ ionophore 
ionomycin (5 PM). The total Ca2+ mobilized by 
TLC and by the messenger was about 
0.5 nmol/mg cell protein, which approximates the 
amounts of Ca2+ mobilized by vasopressin in in- 
tact hepatocytes [4,6]. 
When added to the internal medium lacking 
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Fig.3. Effect of neomycin on the Ca2+ release at different 
concentrations of (A) Ins (1,4,5)Pp and (B) TLC in 
permeabilized hepatocytes. The Ca*+ mobilized from the cells 
was expressed as a percentage of the Ca*+ released by iono- 
mycin (5 PM) and was calculated as indicated in section 2. 
cells, neomycin (1 mM) did not alter the optical 
properties of the Ca2+ indicator quin2, maximal 
binding or affinity of the molecule for Ca2+. In the 
presence of permeabilized hepatocytes, it had no 
effect on the ability of cells to concentrate Ca2+ in 
ER, as illustrated by the fact that the final [Ca2’] 
values found in the medium were equal in controls 
and in neomycin-treated cells (respectively 176 + 
13 nM, n = 58 and 158 f 7.1 nM, n = 43). Fig.2B 
shows the effect of neomycin on the Ca2+ release 
initiated by Ins (1,4,5)P3 and TLC. In agreement 
with other studies [20,26], a concentration of 
1 mM neomycin markedly impaired the ability of 
Ins (1,4,5)P3 (1 PM) to release Ca2+ from 
permeabilized cells. In contrast, the antibiotic did 
not alter the TLC-mediated Ca2+ release. The 
results of experiments performed at different con- 
centrations of Ins (1,4,5)P3 and TLC are shown in 
fig.3. The effect of 1 PM Ins (1,4,5)P3 that released 
75% of the Ca2+ accumulated by the control cells 
was reduced to 19% in the presence of the an- 
tibiotic. Consistent with the observation reported 
by Prentki et al. [20] on Ins (1,4,5)P3 binding by 
neomycin, the drug shifted the dose-response curve 
of Ins (1,4,5)P3 action. In other terms, neomycin 
markedly inhibited the effects of low concentra- 
tions of Ins (1,4,5)P3 and the magnitude of the in- 
hibition progressively diminished as the Ins 
(1,4,5)P3 concentration was increased. From the 
data shown in fig.3, it may be estimated that about 
lo-times higher concentrations of Ins (1,4,5)P3 
were required for recovering the same effect of the 
messenger. This effectiveness of neomycin in 
reducing the effect of Ins (1,4,5)P3 and its lack of 
effect on the TLC-mediated Ca2+ release support 
the view that bile acid mobilizes Ca2+ via a direct 
action on ER in liver cells. 
4. DISCUSSION 
Neomycin is a polycationic molecule which 
binds to polyphosphoinositides [ 141, whose 
degradation by phospholipase C leads to forma- 
tion of Ins (1,4,5)P3 and diacylglycerol [3-71. So, 
it has been largely used to assess the involvement 
of PIP2 breakdown in the stimulation-response 
coupling of a variety of cell functions 
[15-19,25,26]. In a recent study, Prentki et al. [20] 
showed that in addition to polyphosphoinositides, 
neomycin is able to bind to other polyanionic 
molecules, particularly Ins (1,4,5)P3 which ac- 
counts for the inhibition of the Ca2+ release in- 
duced by added Ins (1,4,5)P3 in permeabilized 
cells. In the present work, we have used this prop- 
erty of the molecule to bind to Ins (1,4,5)P3 to 
assess the involvement of the intracellular 
messenger in the TLC-mediated Ca2+ release in 
liver. Neomycin does not affect the ability of ER 
to pump actively Ca2+ in saponin-treated 
hepatocytes. In agreement with Prentki et al. [20], 
it markedly inhibits the Ca2+ release induced by Ins 
(1,4,5)P3 in rat liver cells. Since the antibiotic did 
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not affect the releasing action of TLC, our results 
demonstrate that the effect of TLC is not mediated 
by Ins (1,4,5)P3. The question is of importance 
since TLC mimicks the action of the 
PIPz-dependent hormone vasopressin in intact 
hepatocytes and the effect of Ins (1,4,5)P3 in 
permeabilized cells [1,2]. Our results rule out the 
possibility that the bile acid could have promoted 
a local increase of Ins (1,4,5)P3 in the vicinity of 
messenger eceptors [28], too small to be easily 
detected by chromatography but large enough to 
cause Ca2+ release from ER. 
The mechanism by which TLC controls the Ca2+ 
permeability of ER is not yet known [2]. An 
ionophore-like effect on Ca2+ permeability ap- 
pears unlikely, since TLC has been shown to 
permeabilize selectively ER without altering ion 
permeabilities of plasma and mitochondrial mem- 
branes [2]. An ionophore-like effect is not likely to 
be specific for a particular membrane. It is possible 
that TLC might bind to specific receptors and 
permeabilize the membrane of liver ER in a way 
similar (but independent) to Ins (1,4,5)P3 [8,9,29]. 
The natural bile acids are rapidly accumulated 
by hepatocytes from plasma, then actively secreted 
at the canalicular pole of cell [31,32]. This net 
transport of bile acids is the driving force responsi- 
ble for native bile formation. The finding that 
TLC permeabilizes ER strongly supports a role for 
Ca2+ in this process. The monohydroxylated bile 
acids such as TLC and LC are known to reduce 
dramatically bile secretion when injected into rats 
or hamsters [32,33]. Both mobilize Ca2+ from ER 
in intact cells and in saponin-treated hepatocytes 
([2] and present results for the action of TLC). 
Since bile secretion is believed to be dependent on 
Ca2+ (see [33] for references), it is conceivable that 
ER permeabilization to Ca2+ could be at the origin 
of the inhibition of bile secretion. This internal 
compartment plays a major role in the control of 
cell Ca2+ [6,7]. A sustained permeabilization of ER 
by TLC should alter Ca2+-dependent functions, in- 
cluding bile acid secretion and cell hormone 
responses. 
In conclusion, neomycin, via its ability to bind 
inositol polyphosphate groups, discriminates the 
Ca2+ releases initiated by the bile acids and Ins 
(1,4,5)P3. This suggests that the bile acid increases 
[Ca’+]i and stimulates cell Ca2+ efflux in intact 
hepatocytes [2] by directly permeabilizing ER. 
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